All-in-one_nasal-swab_Dx_for_ respiratory_viruses_gets_full_FDA_approval—(not_just_an_EUA): https://www.prnewswire.com/news-releases/fda-permits-marketing-of-first-sars-cov-2-diagnostic-test-using-traditional-premarket-review-process-301249713.html Bullish for ENTA for the reason mentioned in #msg-156795547. BioFire Diagnostics LLC, the company selling this test, is private.